相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
Henry R. Kranzler et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
A review of the existing literature on buprenorphine pharmacogenomics
Christopher W. Meaden et al.
PHARMACOGENOMICS JOURNAL (2021)
Shared genetic and experimental links between obesity-related traits and asthma subtypes in UK Biobank
Zhaozhong Zhu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder
Andrew D. Peckham et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder A Genome-Wide Association Study
Hang Zhou et al.
JAMA PSYCHIATRY (2020)
Expanding the genetic architecture of nicotine dependence and its shared genetics with multiple traits
Bryan C. Quach et al.
NATURE COMMUNICATIONS (2020)
Depression and Outcomes of Methadone and Buprenorphine Treatment among People with Opioid Use Disorders: A Literature Review
Maykel Farag Ghabrash et al.
JOURNAL OF DUAL DIAGNOSIS (2020)
A systematic review of genome-wide association studies of antipsychotic response
Josiah D. Allen et al.
PHARMACOGENOMICS (2019)
Co-occurring substance use and mental disorders among adults with opioid use disorder
Christopher M. Jones et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations
Henry R. Kranzler et al.
NATURE COMMUNICATIONS (2019)
Harmonizing Genetic Ancestry and Self-identified Race/Ethnicity in Genome-wide Association Studies
Huaying Fang et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Weight Loss Results in Increased Expression of Anti-Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue
Robert M. Jackson et al.
OBESITY (2019)
VA Primary Care and Mental Health Providers' Comfort with Genetic Testing: Survey Results from the PRIME Care Study
Leland E. Hull et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African-Americans with opioid use disorder
Richard C. Crist et al.
PHARMACOGENOMICS JOURNAL (2019)
Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients
David M. Ledgerwood et al.
ADDICTIVE BEHAVIORS (2019)
Review: Sex-Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder
Andrew S. Huhn et al.
AMERICAN JOURNAL ON ADDICTIONS (2019)
A polymorphism in the OPRM1 3 '-untranslated region is associated with methadone efficacy in treating opioid dependence
R. C. Crist et al.
PHARMACOGENOMICS JOURNAL (2018)
Trends and key correlates of prescription opioid injection misuse in the United States
Christopher M. Jones
ADDICTIVE BEHAVIORS (2018)
Molecular Genetic Analysis Subdivided by Adversity Exposure Suggests Etiologic Heterogeneity in Major Depression
Roseann E. Peterson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality A Cohort Study
Marc R. Larochelle et al.
ANNALS OF INTERNAL MEDICINE (2018)
Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1
A. H. Smith et al.
MOLECULAR PSYCHIATRY (2017)
Functional mapping and annotation of genetic associations with FUMA
Kyoko Watanabe et al.
NATURE COMMUNICATIONS (2017)
The impact of mental health comorbidities on adherence to buprenorphine: A claims based analysis
Megan Litz et al.
AMERICAN JOURNAL ON ADDICTIONS (2017)
Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits
J. C. Maranville et al.
PHARMACOGENOMICS JOURNAL (2016)
Million Veteran Program: A mega-biobank to study genetic influences on health and disease
John Michael Gaziano et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Identification of SLC25A37 as a major depressive disorder risk gene
Yong-Xia Huo et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study
Liping Hou et al.
LANCET (2016)
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration
Margaret T. May et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
Kristin G. Ardlie et al.
SCIENCE (2015)
MAGMA: Generalized Gene-Set Analysis of GWAS Data
Christiaan A. de Leeuw et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Yih-Ing Hser et al.
ADDICTION (2014)
ALDH5A1 variability in opioid dependent patients could influence response to methadone treatment
Francina Fonseca et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke et al.
NATURE (2014)
Genetic variation in OPRD1 and the response to treatment for opioid dependence with buprenorphine in European-American females
T-K Clarke et al.
PHARMACOGENOMICS JOURNAL (2014)
Association between gene variants and response to buprenorphine maintenance treatment
Gilberto Gerra et al.
PSYCHIATRY RESEARCH (2014)
Emerging adult age status predicts poor buprenorphine treatment retention
Zev Schuman-Olivier et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2014)
Predictive Factors for Relapse in Patients on Buprenorphine Maintenance
Michael Ferri et al.
AMERICAN JOURNAL ON ADDICTIONS (2014)
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study
Jessica A. Dreifuss et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment
Jonathan D. Savant et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START)
Jennifer S. Potter et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2013)
An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans
Richard C. Crist et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Predictors of methadone program non-retention for opioid analgesic dependent patients
Joseph Cox et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2013)
Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth
Geetha A. Subramaniam et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2011)
β-Arrestin2 influences the response to methadone in opioid-dependent patients
B. Oneda et al.
PHARMACOGENOMICS JOURNAL (2011)
Comparing Injection and Non-Injection Routes of Administration for Heroin, Methamphetamine, and Cocaine Users in the United States
Scott P. Novak et al.
JOURNAL OF ADDICTIVE DISEASES (2011)
Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes
Francina Fonseca et al.
MOLECULAR DIAGNOSIS & THERAPY (2010)
Genotype imputation for genome-wide association studies
Jonathan Marchini et al.
NATURE REVIEWS GENETICS (2010)
The Association between Cocaine Use and Treatment Outcomes in Patients Receiving Office-Based Buprenorphine/Naloxone for the Treatment of Opioid Dependence
Lynn E. Sullivan et al.
AMERICAN JOURNAL ON ADDICTIONS (2010)
BDNF variability in opioid addicts and response to methadone treatment:: preliminary findings
R. de Cid et al.
GENES BRAIN AND BEHAVIOR (2008)
Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment
Severine Crettol et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients
Brent A. Moore et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse
Dawn N. Albertson et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Brief report: Buprenorphine retention in primary care
MD Stein et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2005)
Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin
DN Albertson et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome
G Gerra et al.
DRUG AND ALCOHOL DEPENDENCE (2004)
分享论文
